EBV positive tumours display a distinct tumorigenic profile which includes robust PD-L1 expression, amplifications of chromosomal region 9p24.1, that encode PD-1 ligands, JAK2 amplifications, higher prevalence of DNA hypermethylation, recurrent PIK3CA mutations and different patterns of immune infiltrates [59]. The gene discussed is CD274; the disease is neoplasm.